Guangdi Wang

Dr. Guangdi Wang is the founder of Endotarge, a company developing degraders against HIV infections. He also founded Zenopharm, which is developing novel therapeutic products for the treatment of breast and other cancers. He hold the position of Professor of Chemistry in the Department of Chemistry, Xavier University of Louisiana. He also holds adjunct faculty positions at Tulane University and the University of New Orleans where he collaborates with Professors John McLachlan, Matthew Burow, and Richard Cole on research involving proteomic analyses of breast cancer cells and fibroid cells. Dr. Wang holds a Ph.D. in Analytical Chemistry from the University of New Orleans. His graduate research focused on the fundamental aspects of mass spectrometry, which gave him extensive experience in sophisticated mass spectrometric techniques and their biomedical applications.